Cyclooxygenase-2 knockdown using retinoic acid chalcone (RAC), a promising therapeutic strategy for colon cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Cancer Research

• Publication date

  2015-05-15

• Fields of study

  Medicine

• Identifiers
  PMID 26269760PMCID PMC4529620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dose translation from animal to human studies revisited

  2007cited by this paper
• 15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer*

  2005cited by this paper
• 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.

  2004cited by this paper
• Multifaceted roles of cyclooxygenase-2 in lung cancer.

  2004cited by this paper
• Prostaglandin E2 Protects Gastric Mucosal Cells from Apoptosis via EP2 and EP4 Receptor Activation*

  2003cited by this paper
• EP2 and EP4 prostanoid receptor signaling.

  2003cited by this paper
• The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-κB and Bad

  2003cited by this paper
• The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad.

  2003cited by this paper
• Prostaglandin catabolizing enzymes.

  2002cited by this paper
• Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

  2002cited by this paper
• Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia

  2002cited by this paper
• Cyclooxygenase‐2 expression during carcinogenesis in the human stomach

  2002cited by this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

  2002cited by this paper
• Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells*

  2001cited by this paper
• Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis

  2001cited by this paper
• Cyclooxygenase-2: a novel target for cancer chemotherapy?

  2001cited by this paper
• Intracellular unesterified arachidonic acid signals apoptosis.

  2000cited by this paper
• Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.

  2000cited by this paper
• Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155.

  2000cited by this paper
• COX‐2 is expressed in human pulmonary, colonic, and mammary tumors

  2000cited by this paper
• The role of cyclooxygenases in inflammation, cancer, and development

  1999cited by this paper
• Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.

  1999cited by this paper
• Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers.

  1999cited by this paper
• Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.

  1998cited by this paper
• Expression of cyclooxygenase-2 in human lung carcinoma.

  1998cited by this paper
• All‐TRANS, 13‐CIS and 9‐CIS retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: Implications for in vivo retinoic acid use

  1997cited by this paper
• All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications

  1997cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Prostaglandin endoperoxide H synthases-1 and -2.

  1996cited by this paper
• Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

  1995cited by this paper
• Retinoic acid induced death of ovarian carcinoma cells correlates with c‐myc stimulation

  1995cited by this paper
• Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

  1995cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer.

  1994cited by this paper
• Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.

  1992cited by this paper
• Solubility of retinoids in water.

  1991cited by this paper
• Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

  1988cited by this paper
• Percutaneous absorption of retinoids: influence of vehicle, light exposure, and dose.

  1988cited by this paper
• Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

  1988cited by this paper

• Divergent gene expression of PTGS1 and PTGS2 along the disease course of chronic myeloid leukaemia

  2025cites this paper
• Chalcones and Gastrointestinal Cancers: Experimental Evidence

  2023influential citation
• 13-cis-retinoic acid inhibits the self-renewal, migration, invasion and adhesion of cholangiocarcinoma cells

  2023cites this paper
• Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.

  2022cites this paper
• Regulation of inflammation and COX-2 gene expression in benzo (a) pyrene induced lung carcinogenesis in mice by all trans retinoic acid (ATRA).

  2021cites this paper
• Inhibition of Ep3 attenuates migration and promotes apoptosis of non-small cell lung cancer cells via suppression of TGF-β/Smad signaling

  2018cites this paper
• Quantitative Structure-Cytotoxicity Relationship of Chalcones.

  2017cites this paper
• The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy

  2017cites this paper
• Methanolic extract of Boswellia serrata exhibits anti-cancer activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells.

  2017cites this paper
• In vitro anticancer activity of new gold(III) porphyrin complexes in colon cancer cells.

  2017cites this paper
• Resistance to 3‐HTMC‐Induced Apoptosis Through Activation of PI3K/Akt, MEK/ERK, and p38/COX‐2/PGE2 Pathways in Human HT‐29 and HCT116 Colorectal Cancer Cells

  2016cites this paper
• Aspirin, platelets, and cancer: The point of view of the internist.

  2016cites this paper
• Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression

  2016cites this paper
• Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.

  2016cites this paper